Evidence map›Paper›PMID 39315078›Full record

ArticleFrontiers in neuroscience2024

The protean presentations of XK disease (McLeod syndrome): a case series with new observations and updates on previously reported families.

Ruth H Walker, Mariana Barreto, James R Bateman, M Leonor Bustamante, Graham Chiu, Scott Feitell, Beat M Frey, Patricio Guerra, Sofia Guerrero, Hans H Jung and 16 more

Abstract read
In one paragraph

Article in Frontiers in neuroscience, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

26 authors.

Ruth H WalkerDepartment of Neurology, James J. Peters Veterans Affairs Medical Center, New York, NY, United States.
Mariana BarretoDiagnosis Foundation, Santiago, Chile.
James R BatemanMental Health Service Line and the Mental Illness Research, Education, and Clinical Center, W.G. (Bill) Hefner Salisbury Veterans Affairs Medical Center, Salisbury, NC, United States.
M Leonor BustamanteDiagnosis Foundation, Santiago, Chile.
Graham ChiuRheumatologist, Palmerston North, New Zealand.
Scott FeitellRochester Regional Health, Sands-Constellation Heart Institute, Rochester, NY, United States.
Beat M FreyRegional Blood Transfusion Service, Swiss Red Cross, Zurich, Switzerland.
Patricio GuerraSchool of Medicine, University San Sebastián, Puerto Montt, Chile.
Sofia GuerreroHospital De Castro, Los Lagos, Chile.
Hans H JungDepartment of Neurology, University Hospital, Zurich, Switzerland.
Fernando MaldonadoServicio Salud Reloncaví, Puerto Montt, Chile.
Eduardo MeyerRegional Blood Transfusion Service, Swiss Red Cross, Zurich, Switzerland.
Marcelo MirandaDiagnosis Foundation, Santiago, Chile.
Emelie McFarlandMental Health Service Line and the Mental Illness Research, Education, and Clinical Center, W.G. (Bill) Hefner Salisbury Veterans Affairs Medical Center, Salisbury, NC, United States.
Patricia OatesRochester Regional Health, Sands-Constellation Heart Institute, Rochester, NY, United States.
Gorka OchoaNew York Blood Center Enterprises, New York, NY, United States.
Karin OlssonDepartment of Neurology, Karolinska University Hospital, Stockholm, Sweden.
Martin PaucarDepartment of Neurology, Karolinska University Hospital, Stockholm, Sweden.
Jonatan Alvarez ProschleIndependent Researcher, Puerto Varas, Chile.
Esther M SammlerUniversity of Dundee, School of Medicine, Dundee, Scotland.
Monica TroncosoHospital San Borja Arriaran, University of Chile, Santiago, Chile.
Rachel Wu-WallaceMental Health Service Line and the Mental Illness Research, Education, and Clinical Center, W.G. (Bill) Hefner Salisbury Veterans Affairs Medical Center, Salisbury, NC, United States.
Leo YoungMental Health Service Line and the Mental Illness Research, Education, and Clinical Center, W.G. (Bill) Hefner Salisbury Veterans Affairs Medical Center, Salisbury, NC, United States.
Sunitha VegeNew York Blood Center Enterprises, New York, NY, United States.
Connie M WesthoffNew York Blood Center Enterprises, New York, NY, United States.
Adrian DanekDepartment of Neurology, LMU University Hospital, LMU Munich, Munich, Germany.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

XK disease is a very rare, multi-system disease, which can present with a wide spectrum of symptoms. This disorder can also be identified pre-symptomatically with the incidental detection of serological abnormalities when typing erythrocytes in peripheral blood, or on other routine laboratory testing. Increasing awareness of this disorder and improved access to genetic testing are resulting in increasing identification of affected patients and families. Here we provide updates to some previously-reported families and patients and provide additional clinical details. We also report four new cases with a variety of presentations, one of whom had a novel mutation.

Indexed as

acanthocytosischoreaMcLeodneurodegenerationXK

Identifiers

PMID39315078
PMCPMC11417094

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.